Phase III clinical studies development in US

Development and execution of the medical department and action plan projects for Multiple Sclerosis products.Pre-launch, launch and post-launch activities for a new drug.Internal medical and scientific training.Medical visits with MSLs and ABMs.Cross-functional project management for the hospital products marketplace.

- Trans CD4 immunotherapy with an innovative drug.- Protocols development following the SOPs for the proof of concepts of the novel drug. - Biotechnological equipment management for the preclinical studies improvement.- Carrying out and implementation the experimental plan for the PS of the new treatment.- Blocking a molecular mechanism leading to CD4 anergy. - Late-stage of preclinical studies aim to restore the CD4 T-cells ability to fight: * HIV * Pancreatic cancer

- Acquisition of a strong professional experience in Immunology and Oncology- B cells and the activation events that lead to the humoral immune response- State-of-the-art imaging techniques- In vitro and in vivo experimental models- Publication in scientific journals of impact in the field- Collaboration with other research groups and contribution with my expertise in imaging and lymphocyte biology to the progress of research projects- Contribution to scientific community with communications in National and International congresses

- Study of B cell dynamics- Mouse models and different in vitro technics- Study of an oncogenic biomarker in B cells immune response.

- Short-Term Grant, Ministry of Science, Innovation and Universities - Spanish government- Use of high-quality image techniques for biophysics studies in B lymphocytes- Full-time collaboration abroad to complete my thesis work publication

- Short-Term Grant, Ministry of Science, Innovation and Universities - Spanish government- Manage of “sole-in-class” image technique for biophysics studies in the B cell immune synapse- Full-time collaboration abroad to complete my thesis work publication

- Different in vitro studies in Immunology - Immune response against different clinical challenges in Sepsis - Study of cellular markers and production of cytokines in human monocytes and macrophages tolerant to endotoxins.